Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

TPP2 mutation associated with sterile brain inflammation mimicking MS.

Reinthaler EM, Graf E, Zrzavy T, Wieland T, Hotzy C, Kopecky C, Pferschy S, Schmied C, Leutmezer F, Keilani M, Lill CM, Hoffjan S, Epplen JT, Zettl UK, Hecker M, Deutschländer A, Meuth SG, Ahram M, Mustafa B, El-Khateeb M, Vilariño-Güell C, Sadovnick AD, Zimprich F, Tomkinson B, Strom T, Kristoferitsch W, Lassmann H, Zimprich A.

Neurol Genet. 2018 Nov 13;4(6):e285. doi: 10.1212/NXG.0000000000000285. eCollection 2018 Dec.

2.

Month-of-birth-effect in multiple sclerosis in Austria.

Walleczek NK, Frommlet F, Bsteh G, Eggers C, Rauschka H, Koppi S, Assar H, Ehling R, Birkl C, Salhofer-Polanyi S, Baumgartner A, Blechinger S, Buchinger D, Sellner J, Kraus J, Moser H, Mayr M, Guger M, Rathmaier S, Raber B, Liendl H, Hiller MS, Parigger S, Morgenstern G, Kempf I, Spiss HK, Meister B, Heine M, Cisar A, Bachler H, Khalil M, Fuchs S, Enzinger C, Fazekas F, Leutmezer F, Berger T, Kristoferitsch W, Aboulenein-Djamshidian F.

Mult Scler. 2018 Nov 22:1352458518810924. doi: 10.1177/1352458518810924. [Epub ahead of print]

PMID:
30463473
3.

Secondary dementia due to Lyme neuroborreliosis.

Kristoferitsch W, Aboulenein-Djamshidian F, Jecel J, Rauschka H, Rainer M, Stanek G, Fischer P.

Wien Klin Wochenschr. 2018 Aug;130(15-16):468-478. doi: 10.1007/s00508-018-1361-9. Epub 2018 Jul 25.

4.

To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis - Author's reply.

Dessau RB, van Dam AP, Fingerle V, Gray J, Hovius JW, Hunfeld KP, Jaulhac B, Kahl O, Kristoferitsch W, Lindgren PE, Markowicz M, Mavin S, Ornstein K, Rupprecht T, Stanek G, Strle F.

Clin Microbiol Infect. 2018 Feb;24(2):211-212. doi: 10.1016/j.cmi.2017.10.011. Epub 2017 Oct 24. No abstract available.

5.

To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis.

Dessau RB, van Dam AP, Fingerle V, Gray J, Hovius JW, Hunfeld KP, Jaulhac B, Kahl O, Kristoferitsch W, Lindgren PE, Markowicz M, Mavin S, Ornstein K, Rupprecht T, Stanek G, Strle F.

Clin Microbiol Infect. 2018 Feb;24(2):118-124. doi: 10.1016/j.cmi.2017.08.025. Epub 2017 Sep 5. Review.

6.

Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins.

Brändle SM, Obermeier B, Senel M, Bruder J, Mentele R, Khademi M, Olsson T, Tumani H, Kristoferitsch W, Lottspeich F, Wekerle H, Hohlfeld R, Dornmair K.

Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7864-9. doi: 10.1073/pnas.1522730113. Epub 2016 Jun 20.

7.

Optical coherence tomography in multiple sclerosis.

Aboulenein-Djamshidian F, Serbecic N, Kristoferitsch W.

Lancet Neurol. 2016 May;15(6):537-8. doi: 10.1016/S1474-4422(16)00113-7. Epub 2016 Mar 24. No abstract available.

PMID:
27017471
8.

CROP - The Clinico-Radiologico-Ophthalmological Paradox in Multiple Sclerosis: Are Patterns of Retinal and MRI Changes Heterogeneous and Thus Not Predictable?

Aboulenein-Djamshidian F, Krššák M, Serbecic N, Rauschka H, Beutelspacher S, Kukurová IJ, Valkovič L, Khan A, Prayer D, Kristoferitsch W.

PLoS One. 2015 Nov 13;10(11):e0142272. doi: 10.1371/journal.pone.0142272. eCollection 2015.

9.

Clinicopathological description of two cases with SQSTM1 gene mutation associated with frontotemporal dementia.

Kovacs GG, van der Zee J, Hort J, Kristoferitsch W, Leitha T, Höftberger R, Ströbel T, Van Broeckhoven C, Matej R.

Neuropathology. 2016 Feb;36(1):27-38. doi: 10.1111/neup.12233. Epub 2015 Aug 3.

PMID:
26234378
10.

Corrigendum: "High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II - The Total Macular Volume. The First Follow-Up Study Over 2 Years".

Serbecic N, Aboulenein-Djamshidian F, Beutelspacher SC, Khan A, Vass C, Kristoferitsch W, Reitner A, Schmidt-Erfurth U.

Front Neurol. 2015 Jun 4;6:131. doi: 10.3389/fneur.2015.00131. eCollection 2015.

11.

Reduction in serum aquaporin-4 antibody titers during development of a tumor-like brain lesion in a patient with neuromyelitis optica: a serum antibody-consuming effect?

Aboulenein-Djamshidian F, Höftberger R, Waters P, Krampla W, Lassmann H, Budka H, Vincent A, Kristoferitsch W.

J Neuropathol Exp Neurol. 2015 Mar;74(3):194-7. doi: 10.1097/NEN.0000000000000173.

12.

The authors reply to comments on "The lymphocyte transformation test for the diagnosis of Lyme borreliosis has currently not been shown to be clinically useful." Clin Microbiol Infect 2014;20:O786-O787.

Dessau RB, Fingerle V, Gray J, Hunfeld KP, Jaulhac B, Kristoferitsch W, Stanek G, Strle F.

Clin Microbiol Infect. 2015 Mar;21(3):e21. doi: 10.1016/j.cmi.2014.08.013. Epub 2014 Oct 29. No abstract available.

13.

High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II - the Total Macular Volume. The First Follow-Up Study over 2 Years.

Serbecic N, Aboul-Enein F, Beutelspacher SC, Khan A, Vass C, Kristoferitsch W, Reitner A, Schmidt-Erfurth U.

Front Neurol. 2014 Feb 24;5:20. doi: 10.3389/fneur.2014.00020. eCollection 2014. Erratum in: Front Neurol. 2015;6:131.

14.

The lymphocyte transformation test for the diagnosis of Lyme borreliosis has currently not been shown to be clinically useful.

Dessau RB, Fingerle V, Gray J, Hunfeld KP, Jaulhac B, Kahl O, Kristoferitsch W, Stanek G, Strle F.

Clin Microbiol Infect. 2014 Oct;20(10):O786-7. doi: 10.1111/1469-0691.12583. Epub 2014 Mar 6. No abstract available.

15.

Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people.

Aboul-Enein F, Seifert-Held T, Mader S, Kuenz B, Lutterotti A, Rauschka H, Rommer P, Leutmezer F, Vass K, Flamm-Horak A, Stepansky R, Lang W, Fertl E, Schlager T, Heller T, Eggers C, Safoschnik G, Fuchs S, Kraus J, Assar H, Guggenberger S, Reisz M, Schnabl P, Komposch M, Simschitz P, Skrobal A, Moser A, Jeschow M, Stadlbauer D, Freimüller M, Guger M, Schmidegg S, Franta C, Weiser V, Koppi S, Niederkorn-Duft M, Raber B, Schmeissner I, Jecel J, Tinchon A, Storch MK, Reindl M, Berger T, Kristoferitsch W.

PLoS One. 2013 Nov 5;8(11):e79649. doi: 10.1371/journal.pone.0079649. eCollection 2013.

16.

Lyme neuroborreliosis.

Hansen K, Crone C, Kristoferitsch W.

Handb Clin Neurol. 2013;115:559-75. doi: 10.1016/B978-0-444-52902-2.00032-1. Review.

PMID:
23931802
17.

No evidence for a role of rare CYP27B1 variants in Austrian multiple sclerosis patients.

Reinthaler E, Machetanz G, Hotzy C, Reindl M, Fazekas F, Kristoferitsch W, Berger T, Schmied C, Zimprich A.

Mult Scler. 2014 Mar;20(3):391-2. doi: 10.1177/1352458513498130. Epub 2013 Jul 25. No abstract available.

PMID:
23886824
18.

Natalizumab therapy for highly active pediatric multiple sclerosis.

Kornek B, Aboul-Enein F, Rostasy K, Milos RI, Steiner I, Penzien J, Hellwig K, Pitarokoili K, Storm van's Gravesande K, Karenfort M, Blaschek A, Meyer A, Seidl R, Debelic D, Vass K, Prayer D, Kristoferitsch W, Bayas A.

JAMA Neurol. 2013 Apr;70(4):469-75. doi: 10.1001/jamaneurol.2013.923.

PMID:
23420110
19.

Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry.

Jarius S, Franciotta D, Paul F, Bergamaschi R, Rommer PS, Ruprecht K, Ringelstein M, Aktas O, Kristoferitsch W, Wildemann B.

J Neurol Sci. 2012 Sep 15;320(1-2):32-7. doi: 10.1016/j.jns.2012.06.002. Epub 2012 Jun 16.

PMID:
22705047
20.

Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patients.

Schmied MC, Zehetmayer S, Reindl M, Ehling R, Bajer-Kornek B, Leutmezer F, Zebenholzer K, Hotzy C, Lichtner P, Meitinger T, Wichmann HE, Illig T, Gieger C, Huber K, Khalil M, Fuchs S, Schmidt H, Auff E, Kristoferitsch W, Fazekas F, Berger T, Vass K, Zimprich A.

Neurogenetics. 2012 May;13(2):181-7. doi: 10.1007/s10048-012-0316-y. Epub 2012 Mar 14.

PMID:
22411505
21.

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.

Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K, Lutterotti A, Jarius S, Di Pauli F, Kuenz B, Ehling R, Hegen H, Deisenhammer F, Aboul-Enein F, Storch MK, Koson P, Drulovic J, Kristoferitsch W, Berger T, Reindl M.

J Neuroinflammation. 2011 Dec 28;8:184. doi: 10.1186/1742-2094-8-184.

22.

Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature.

Jarius S, Paul F, Franciotta D, de Seze J, Münch C, Salvetti M, Ruprecht K, Liebetrau M, Wandinger KP, Akman-Demir G, Melms A, Kristoferitsch W, Wildemann B.

Mult Scler. 2012 Aug;18(8):1135-43. doi: 10.1177/1352458511431728. Epub 2011 Dec 19. Review.

PMID:
22183934
23.

High resolution spectral domain optical coherence tomography (SD-OCT) in multiple sclerosis: the first follow up study over two years.

Serbecic N, Aboul-Enein F, Beutelspacher SC, Vass C, Kristoferitsch W, Lassmann H, Reitner A, Schmidt-Erfurth U.

PLoS One. 2011;6(5):e19843. doi: 10.1371/journal.pone.0019843. Epub 2011 May 17.

24.

Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.

Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R, Rommer P, Kleiter I, Stich O, Reuss R, Rauer S, Zettl UK, Wandinger KP, Melms A, Aktas O, Kristoferitsch W, Wildemann B.

J Neurol Sci. 2011 Jul 15;306(1-2):82-90. doi: 10.1016/j.jns.2011.03.038. Epub 2011 May 6.

PMID:
21550068
25.

Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.

Jarius S, Jacobi C, de Seze J, Zephir H, Paul F, Franciotta D, Rommer P, Mader S, Kleiter I, Reindl M, Akman-Demir G, Seifert-Held T, Kristoferitsch W, Melms A, Wandinger KP, Wildemann B.

Mult Scler. 2011 Sep;17(9):1067-73. doi: 10.1177/1352458511403958. Epub 2011 May 4.

PMID:
21543553
26.

Heterogeneous pattern of retinal nerve fiber layer in multiple sclerosis. High resolution optical coherence tomography: potential and limitations.

Serbecic N, Aboul-Enein F, Beutelspacher SC, Graf M, Kircher K, Geitzenauer W, Brannath W, Lang P, Kristoferitsch W, Lassmann H, Reitner A, Schmidt-Erfurth U.

PLoS One. 2010 Nov 8;5(11):e13877. doi: 10.1371/journal.pone.0013877.

27.

Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis.

Jarius S, Frederikson J, Waters P, Paul F, Akman-Demir G, Marignier R, Franciotta D, Ruprecht K, Kuenz B, Rommer P, Kristoferitsch W, Wildemann B, Vincent A.

J Neurol Sci. 2010 Nov 15;298(1-2):158-62. doi: 10.1016/j.jns.2010.07.011. Epub 2010 Sep 18.

PMID:
20850793
28.

Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance.

Jarius S, Franciotta D, Paul F, Ruprecht K, Bergamaschi R, Rommer PS, Reuss R, Probst C, Kristoferitsch W, Wandinger KP, Wildemann B.

J Neuroinflammation. 2010 Sep 8;7:52. doi: 10.1186/1742-2094-7-52.

29.

Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla.

Aboul-Enein F, Krssák M, Höftberger R, Prayer D, Kristoferitsch W.

PLoS One. 2010 Jul 20;5(7):e11625. doi: 10.1371/journal.pone.0011625.

30.

Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.

Mader S, Lutterotti A, Di Pauli F, Kuenz B, Schanda K, Aboul-Enein F, Khalil M, Storch MK, Jarius S, Kristoferitsch W, Berger T, Reindl M.

PLoS One. 2010 May 5;5(5):e10455. doi: 10.1371/journal.pone.0010455.

31.

Lyme borreliosis: clinical case definitions for diagnosis and management in Europe.

Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, Kristoferitsch W, O'Connell S, Ornstein K, Strle F, Gray J.

Clin Microbiol Infect. 2011 Jan;17(1):69-79. doi: 10.1111/j.1469-0691.2010.03175.x.

32.

Decision-making for and impact of early immunomodulatory treatment: the Austrian Clinically Isolated Syndrome Study (ACISS).

Fazekas F, Baumhackl U, Berger T, Deisenhammer F, Fuchs S, Kristoferitsch W, Ladurner G, Soukop W, Wimmer G, Vass K.

Eur J Neurol. 2010 Jun 1;17(6):852-60. doi: 10.1111/j.1468-1331.2009.02943.x. Epub 2010 Jan 20.

PMID:
20100231
33.

Diffuse white matter damage is absent in neuromyelitis optica.

Aboul-Enein F, Krssák M, Höftberger R, Prayer D, Kristoferitsch W.

AJNR Am J Neuroradiol. 2010 Jan;31(1):76-9. doi: 10.3174/ajnr.A1791. Epub 2009 Sep 12.

34.

Diagnosis of infection with human herpes viruses in routine laboratory practice.

Mostafaie N, Huber KR, Sebesta C, Bauer K, Kristoferitsch W, Volc-Platzer B, Kurz H, Klinghofer I, Mirkovic B, Hofmann J, Hejtman M, Schrattbauer K, Krugluger W.

Clin Chem Lab Med. 2009;47(9):1141-5. doi: 10.1515/CCLM.2009.251.

PMID:
19634984
35.

Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study.

Krampla W, Aboul-Enein F, Jecel J, Lang W, Fertl E, Hruby W, Kristoferitsch W.

Eur Radiol. 2009 Oct;19(10):2535-43. doi: 10.1007/s00330-009-1425-3. Epub 2009 May 5.

PMID:
19415287
36.

Normal pressure hydrocephalus or neuroborreliosis?

Aboul-Enein F, Kristoferitsch W.

Wien Med Wochenschr. 2009;159(1-2):58-61. doi: 10.1007/s10354-008-0581-4.

PMID:
19225737
37.

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.

Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, Berger T, Lang W, Reindl M, Vincent A, Kristoferitsch W.

Brain. 2008 Nov;131(Pt 11):3072-80. doi: 10.1093/brain/awn240. Epub 2008 Oct 22.

38.

Neocortical neurones may be targeted by immune attack in anti-Yo paraneoplastic syndrome.

Aboul-Enein F, Höftberger R, Buxhofer-Ausch V, Drlicek M, Lassmann H, Budka H, Kristoferitsch W.

Neuropathol Appl Neurobiol. 2008 Apr;34(2):248-52. Epub 2007 Nov 9. No abstract available.

PMID:
17995920
39.

Chronic meningitis and lacunar stroke in Fabry disease.

Schreiber W, Udvardi A, Kristoferitsch W.

J Neurol. 2007 Oct;254(10):1447-9. Epub 2007 Oct 25. No abstract available.

PMID:
17940724
40.

Escalating immunotherapy of multiple sclerosis--new aspects and practical application.

Rieckmann P, Toyka KV, Bassetti C, Beer K, Beer S, Buettner U, Chofflon M, Götschi-Fuchs M, Hess K, Kappos L, Kesselring J, Goebels N, Ludin HP, Mattle H, Schluep M, Vaney C, Baumhackl U, Berger T, Deisenhammer F, Fazekas F, Freimüller M, Kollegger H, Kristoferitsch W, Lassmann H, Markut H, Strasser-Fuchs S, Vass K, Altenkirch H, Bamborschke S, Baum K, Benecke R, Brück W, Dommasch D, Elias WG, Gass A, Gehlen W, Haas J, Haferkamp G, Hanefeld F, Hartung HP, Heesen C, Heidenreich F, Heitmann R, Hemmer B, Hense T, Hohlfeld R, Janzen RW, Japp G, Jung S, Jügelt E, Koehler J, Kölmel W, König N, Lowitzsch K, Manegold U, Melms A, Mertin J, Oschmann P, Petereit HF, Pette M, Pöhlau D, Pohl D, Poser S, Sailer M, Schmidt S, Schock G, Schulz M, Schwarz S, Seidel D, Sommer N, Stangel M, Stark E, Steinbrecher A, Tumani H, Voltz R, Weber F, Weinrich W, Weissert R, Wiendl H, Wiethölter H, Wildemann U, Zettl UK, Zipp F, Zschenderlein R, Izquierdo G, Kirjazovas A, Packauskas L, Miller D, Koncan Vracko B, Millers A, Orologas A, Panellus M, Sindic CJ, Bratic M, Svraka A, Vella NR, Stelmasiak Z, Selmaj K, Bartosik-Psujik H, Mitosek-Szewczyk K, Belniak E, Mochecka A, Bayas A, Chan A, Flachenecker P, Gold R, Kallmann B, Leussink V, Mäurer M, Ruprecht K, Stoll G, Weilbach FX; Multiple Sclerosis Therapy Consensus Group.

J Neurol. 2004 Nov;251(11):1329-39. Review.

PMID:
15592728
41.

Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality.

Lobentanz IS, Asenbaum S, Vass K, Sauter C, Klösch G, Kollegger H, Kristoferitsch W, Zeitlhofer J.

Acta Neurol Scand. 2004 Jul;110(1):6-13.

PMID:
15180801
42.

Genetic variants in the tumor necrosis factor receptor II gene in patients with multiple sclerosis.

Ehling R, Gassner Ch, Lutterotti A, Strasser-Fuchs S, Kollegger H, Kristoferitsch W, Reindl M, Berger T.

Tissue Antigens. 2004 Jan;63(1):28-33.

PMID:
14651520
43.

Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis.

Fazekas F, Strasser-Fuchs S, Kollegger H, Berger T, Kristoferitsch W, Schmidt H, Enzinger C, Schiefermeier M, Schwarz C, Kornek B, Reindl M, Huber K, Grass R, Wimmer G, Vass K, Pfeiffer KH, Hartung HP, Schmidt R.

Neurology. 2001 Sep 11;57(5):853-7.

PMID:
11552016
44.

Ganglionitis in paraneoplastic subacute sensory neuronopathy: a morphologic study.

Wanschitz J, Hainfellner JA, Kristoferitsch W, Drlicek M, Budka H.

Neurology. 1997 Oct;49(4):1156-9.

PMID:
9339709
45.

European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis.

Stanek G, O'Connell S, Cimmino M, Aberer E, Kristoferitsch W, Granström M, Guy E, Gray J.

Wien Klin Wochenschr. 1996 Dec 13;108(23):741-7. Review.

PMID:
8990511
46.

T-cell-mediated ganglionitis associated with acute sensory neuronopathy.

Hainfellner JA, Kristoferitsch W, Lassmann H, Bernheimer H, Neisser A, Drlicek M, Beer F, Budka H.

Ann Neurol. 1996 Apr;39(4):543-7. Review.

PMID:
8619534
47.

Neurologic manifestations in Lyme borreliosis.

Kristoferitsch W.

Clin Dermatol. 1993 Jul-Sep;11(3):393-400. Review. No abstract available.

PMID:
8221521
48.

Borrelia burgdorferi infection in Europe: an HLA-related disease?

Reimers CD, Neubert U, Kristoferitsch W, Pflüger KH, Mayr WR.

Infection. 1992 Jul-Aug;20(4):197-200.

PMID:
1521884
49.

Neurological manifestations of Lyme borreliosis.

Kristoferitsch W.

Infection. 1991 Jul-Aug;19(4):268-72. Review. Erratum in: Infection 1991 Sep-Oct;19(5):350.

PMID:
1804127
50.

Neurological manifestations of Lyme borreliosis: clinical definition and differential diagnosis.

Kristoferitsch W.

Scand J Infect Dis Suppl. 1991;77:64-73. Review.

PMID:
1947814

Supplemental Content

Loading ...
Support Center